We Announced the $48.3M Federal Partnership at the White House!
It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me.
While on stage, I couldn’t help but think back to 14 years ago when I was fighting for my life in the ICU. I never could have imagined that one day I would be able to turn those horrible moments into a mission with the potential to help millions of patients all over the world.
The Wall Street Journal Profiled Our Repurposing Work to Help Patients like Kaila
Amy Marcus of the Wall Street Journal profiled Every Cure, the drug repurposing landscape, and patients like Kaila whose life was saved thanks to repurposed drugs that we uncovered! Click here to read the full article.
We are building an AI platform that aims to identify treatments for millions of patients
Every Cure is scaling the approach I used to discover my own cure to unlock additional life-saving uses for every drug. We are using the federal funding to leverage novel AI techniques to analyze the world’s biomedical knowledge and identify 100 potential treatment opportunities in the next five years and advance 25 into further research, including clinical trials. Promising early leads include arginine for sickle cell disease, folinic acid for autism spectrum disorder, and bosutinib for ALS.
Wow, my head is spinning from these recent clinical trial results. Within minutes of one another, two conflicting studies were released. The first I’ll highlight is of tocilizumab (the drug that my friend and colleague Kazu Yoshizaki developed to treat Castleman disease and tested on himself to prove that it was safe before giving it…
I am beyond honored to be named the 2023 Philadelphia Citizen of the Year by The Philadelphia Citizen. This recognition is a testament to our amazing team’s work and the support that so many of you have shared with us! It has been the honor of a lifetime to work with our amazing teams at…
Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed…
It has been amazing to see all of the incredible press and media attention for Chasing My Cure! Check out the various stories below: Chasing My Cure in the press: Good Morning America, August 26, 2019 Philadelphia Magazine, August 28, 2019 Philadelphia Inquirer, September 5, 2019 Next Big Idea Club—Top 6 Nonfiction Books of Fall…
You’ve probably seen the term “cytokine storm” in the news a lot recently. That’s because COVID19 is able to unleash a cytokine storm in the most sick cases. As someone who has survived 5 deadly COVID19-like cytokine storms due to idiopathic multicentric Castleman disease and who studies cytokine storms in my lab, I thought I’d…
Reflecting on 10 Years in Overtime – Time I Never Thought I’d Have At Every Cure, we are utilizing artificial intelligence to identify the most promising new uses for existing drugs across all 3,000 drugs and 20,000 diseases and we need your help to make the biggest impact possible! Whether it’s forwarding this email to a friend or…
